VAS (n = 137) | Placebo (n = 137) | P value or PR (95% CI) | |
---|---|---|---|
At enrolment | |||
Age (days) | 200 (183–294) n = 137 | 198 (183–301) n = 137 | 0.93 |
Weight (kg) | 7.1 (6.1-8.7) n = 88 | 7.5 (5.9-8.8) n = 79 | 0.35 |
MUAC (mm) | 144 (126–160) n = 86 | 144 (130–166) n = 80 | 0.99 |
Breastfeeding | 86/94 (91%) | 80/90 (89%) | 0.55 |
DTP3 vaccinated | 84/137 (61%) | 95/137 (69%) | 0.16 |
At follow up | |||
Age (years) | 7.4 (7.0-7.7) n = 137 | 7.4 (7.0-7.7) n = 137 | 0.72 |
Weight (kg) | 20.0 (17.0-24.0) n = 136 | 20.5 (17.0-23.5) n = 137 | 0.78 |
Height (cm) | 119 (112–126) n = 137 | 118 (111–125) n = 137 | 0.46 |
MUAC (mm) | 166 (150–184) n = 137 | 166 (152–180) n = 137 | 0.77 |
BCG scar | 105/132 (80%) | 110/131 (84%) | 0.35 |
Pig at the house | 43/134 (32%) | 47/133 (35%) | 0.57 |
Atopy in all children (n = 263) | 22/131 (17%) | 18/132 (14%) | 1.23 (0.69-2.18) |
Atopy stratified by sex | |||
Boys (n = 135) | 11/67 (16%) | 7/68 (10%) | 1.60 (0.66-3.90) |
Girls (n = 128) | 11/64 (17%) | 11/64 (17%) | 1.00 (0.46-2.15) |